The Research Behind EECP: What the Studies Actually Show
EECP has one of the more substantial evidence bases among non-invasive circulation therapies, led by the MUST-EECP trial from 1999 and the PEECH trial from 2006, which measured less angina, better exercise tolerance and improved quality of life in randomized studies. Recent systematic reviews continue to support its role while noting that more controlled research is welcome.
Key Points
- MUST-EECP (1999): randomized, sham-controlled, 139 patients with stable angina
- Found fewer anginal episodes and improved exercise tolerance
- PEECH (2006): more EECP patients improved exercise time in heart failure
- A 2010 Circulation study found improved flow-mediated dilation
- Evidence supports appropriate use; it does not promise cure
Where the Evidence Is Strongest
The foundational study is MUST-EECP, a randomized, sham-controlled trial of 139 patients with stable angina published in the Journal of the American College of Cardiology in 1999. It found significant reductions in anginal episodes and nitroglycerin use, and more than 70% of treated patients improved functional status.
The Centers for Medicare and Medicaid Services reviewed this evidence base and issued a National Coverage Determination for external counterpulsation in refractory angina, a major regulatory endorsement of the therapy.
Evidence for Circulation and Blood Vessels
A 2010 study in Circulation, the American Heart Association journal, examined 42 patients with chronic angina in a randomized sham-controlled design. EECP significantly improved flow-mediated dilation, a standard measure of blood vessel function, and reduced angina classification in the treated group.
Evidence in Heart Failure
The PEECH trial randomized 187 patients with mild to moderate heart failure and found that at six months, more EECP patients increased exercise time by 60 seconds or more, with improvements in quality of life.
Each of these trials studied people under medical care with specific conditions. Results in a general wellness population may differ, and individual results always vary.
What the Recent Reviews Say
A 2026 systematic review and meta-analysis in Biomedicines compared EECP with standard medical therapy for chronic refractory angina and found significant reductions in angina severity, while noting heterogeneity across studies and calling for further controlled research.
The honest summary: EECP is a studied, non-invasive therapy with real clinical history, used appropriately under medical guidance, not a miracle treatment.
Reading the Research Yourself
Thrive EECP maintains a research library organized by topic, with each study linked to its primary source so you can verify the details directly. Patients in Draper and across Utah who want EECP usually start by reading the research, then asking questions in a consultation.
Sources & References
Independent, authoritative sources used in this article, linked so you can verify the details yourself. Information here is educational and not a substitute for medical advice.
Want to Explore This Further?
This article is part of the Thrive EECP Health Library in Draper, Utah. If the topic above sounds relevant to you, the next step is a free, no-pressure conversation about your goals.
About the Author
This article was authored and curated by Phil Kim for the Thrive EECP Health Library, with content guidance from the Thrive team. It is educational information, not medical advice, and does not create a patient relationship. Always consult a qualified healthcare professional about your health.
